The cell therapy proved superior to standard-of-care regardless of cytogenetic risk or prior therapy in the CARTITUDE-4 study ...

A new four-drug combination is highly effective and safe in patients with newly diagnosed multiple myeloma, according to data presented at the annual meeting of the American Society of Clinical ...

In the two decades since a young father was diagnosed with multiple myeloma, clinical trials and advances in treating his ...

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of ...

During a live event, Samuel M. Rubinstein, MD, discussed the efficacy and safety outcomes from the KarMMa-3 trial.

A new four-drug combination is highly effective and safe in patients with newly diagnosed multiple myeloma, according to data ...

A potential cure for a rare type of blood cancer is currently being used to treat 150 patients at various healthcare centers ...

Quadruplet therapy is now the accepted standard for patients newly diagnosed with myeloma who are ineligible for transplant; ...

"support the potential for Blenrep combinations to become standard of care" in multiple myeloma patients at or after their first relapse. The company previously teased the overall survival (OS ...

Johnson & Johnson (J&J) has announced that a US Food and Drug Administration (FDA) panel of experts has recommended Darzalex ...